An anonymous reader writes: Neuralstem, a company that has a stem cell procedure to use on ALS has been given the green light for stage 1 testing on humans. The trial has 12 patients that will each get injections in the lumbar portion of their spine. This test is primarily to guarantee the safety of the drug over a known amount of time. Each patient will be watched for signs of problems or rejection of the genetic material. Depending on how the 12 subjects do on this first test 9 on human subjects will determine if the FDA moves ahead to stage 2 testing, which is a larger group that tries to verify that the drug actually performs as advertised. This testing bodes well for Neuralstem as they are the first out the gate with a stem cell treatment to a form of spinal cord injury. If it makes it through all stages of testing, we will see if doctors are willing to se it on subjects that have injuries coming from physical injuries like diving accidents.